secwatch / observer
8-K filed April 24, 2024, 7:59 PM ET CIK 0001409269
debt confidence high sentiment negative materiality 0.75

Venus Concept Inc.: debt financing — Venus Concept enters $5M bridge loan at 12% with Madryn, matures May 26, 2024

Venus Concept Inc.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Venus Concept Inc. incurred term loan of $2,237,906.85 with Madryn Health Partners, LP at 12% maturing May 26, 2024.

Instrument
term loan
Principal
$2,237,906.85
Counterparty
Madryn Health Partners, LP
Rate
12%
Maturity
May 26, 2024
Event
incurrence
Exact text from the filing
the Lenders have agreed to provide the Borrower with bridge financing (the “Bridge Financing”) in the form of a term loan in the original principal amount of $2,237,906.85
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Venus Concept Inc. entered into Loan and Security Agreement with Madryn Health Partners, LP valued at $2,237,906.85 (effective 2024-04-23).

Action
entry
Agreement
credit facility
Counterparty
Madryn Health Partners, LP
Value
$2,237,906.85
Effective
2024-04-23
Exact text from the filing
On April 23, 2024, Venus Concept Inc. (the “Company”) entered into a Loan and Security Agreement (the “Loan and Security Agreement”), by and among Venus Concept USA Inc. (the “Borrower”), Venus Concept Canada Corp. (“Venus Canada”), Venus Concept Ltd. (“Venus Israel”, and together with the Company and Venus Canada, the “Guarantors,” and together with the Borrower, the “Loan Parties”), each lender party thereto (collectively, the “Lenders”) and Madryn Health Partners, LP, as administrative agent (“Madryn”).
View on SEC.gov

316 debt financings filed in the last 30 days. Browse all debt financings →

Source: SEC EDGAR
accession 0001140361-24-021708
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.